MLKL and brain ischemia: In contrast with wild‐type mice, RIPK1 kinase‐dead mice, RIPK3 deficient mice, and MLKL deficient mice showed reduced levels of cell necrosis and neuroinflammation after cerebral ischemia, which is highly consistent with the apoptotic pathway of necrotic cells.